A Novel Electroanalytical Biosensor Based on ZIF-8/Acetylcholinesterase Bio-nanohybrids for Early Management of Hirschsprung Disease
Electroanalysis, ISSN: 1521-4109, Vol: 35, Issue: 2
2023
- 4Citations
- 6Captures
Metric Options: CountsSelecting the 1-year or 3-year option will change the metrics count to percentiles, illustrating how an article or review compares to other articles or reviews within the selected time period in the same journal. Selecting the 1-year option compares the metrics against other articles/reviews that were also published in the same calendar year. Selecting the 3-year option compares the metrics against other articles/reviews that were also published in the same calendar year plus the two years prior.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Example: if you select the 1-year option for an article published in 2019 and a metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019. If you select the 3-year option for the same article published in 2019 and the metric category shows 90%, that means that the article or review is performing better than 90% of the other articles/reviews published in that journal in 2019, 2018 and 2017.
Citation Benchmarking is provided by Scopus and SciVal and is different from the metrics context provided by PlumX Metrics.
Article Description
Hirschsprung's disease (HD) is characterised by missing nerve cells in the colon of infants and children which results in strained bowel movement. Under such situations, undiagnosed and untreated cases often lead to a cascade of gastrointestinal infections eventually resulting in Hirschsprung-assisted enterocolitis which has significantly high mortality rate. This is further exacerbated by the absence of suitable, sensitive and efficient technologies to detect the pathological segment of the intestine, which could significantly reduce surgery duration in the operation theatre, as well as associated risks to patients. It therefore becomes a matter of extreme importance to develop a point-of-care platform for early and efficient management/identification of the occurrence of HD in neonates and older children during its onset, before it proves fatal with life-threatening outcomes. The present work reports an electrochemical enzymatic biosensor using Zeolitic Imidazolate Framework-8 (ZIF-8) modified with acetylcholinesterase enzyme (AchE), for detection of HD as a function of the key biomarker – acetylcholine. The developed sensor was initially characterized using Cyclic Voltammetry (CV) and Electrochemical Impedance Spectroscopy (EIS), while the analytical performance and insights onto interfacial redox kinetics were assessed using Differential Pulse Voltammetry (DPV) and EIS respectively. The sensor exhibited limit of detection and sensitivity of 0.19 μM and sensitivity of 0.42 μA/μM/mm with a shelf life of 1 month, while remaining unperturbed in the presence of common interferants. The performance of developed sensor was also examined in spiked serum samples and was observed to yield a high degree of linearity.
Bibliographic Details
Provide Feedback
Have ideas for a new metric? Would you like to see something else here?Let us know